FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jonathan Cohen

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Concepts & Ideas

Virulence

Anatomy

Cell Line

Co-author Network

Publications

TOP 3
Martin Llewelyn; Shiranee Sriskandan; Nadia Terrazzini; Jonathan Cohen; Daniel M Altmann
The TCR Vbeta signature of bacterial superantigens spreads with stimulus strength.
Shiranee Sriskandan; Melissa Ferguson; Victoria Elliot; Lee Faulkner; Jonathan Cohen
Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
Robert J Edwards; Graham W Taylor; Melissa Ferguson; Stephen Murray; Nigel Rendell; Amanda Wrigley; Zhonghu Bai; Joseph Boyle; Simon J Finney; Angus Jones; Hugh H Russell; Claire Turner; Jonathan Cohen; Lee Faulkner; Shiranee Sriskandan
Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jonathan Cohen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Martin Llewelyn; Shiranee Sriskandan; Nadia Terrazzini; Jonathan Cohen; Daniel M Altmann
The TCR Vbeta signature of bacterial superantigens spreads with stimulus strength.
International immunology 2006;18(10):1433-41.
2006: Shiranee Sriskandan; Melissa Ferguson; Victoria Elliot; Lee Faulkner; Jonathan Cohen
Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
The Journal of antimicrobial chemotherapy 2006;58(1):117-24.
2005: Robert J Edwards; Graham W Taylor; Melissa Ferguson; Stephen Murray; Nigel Rendell; Amanda Wrigley; Zhonghu Bai; Joseph Boyle; Simon J Finney; Angus Jones; Hugh H Russell; Claire Turner; Jonathan Cohen; Lee Faulkner; Shiranee Sriskandan
Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes.
The Journal of infectious diseases 2005;192(5):783-90.
2004: Martin Llewelyn; Shiranee Sriskandan; Mark Peakman; David R Ambrozak; Daniel C Douek; William W Kwok; Jonathan Cohen; Daniel M Altmann
HLA class II polymorphisms determine responses to bacterial superantigens.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(3):1719-26.
2003: Sarah Agyekum; Alison Church; Muhammed Sohail; Thomas Krausz; Susan Van Noorden; Julia Polak; Jonathan Cohen
Expression of lymphotoxin-beta (LT-beta) in chronic inflammatory conditions.
The Journal of pathology 2003;199(1):115-21.
2002: Meera Unnikrishnan; Daniel M Altmann; Thomas Proft; Faisal Wahid; Jonathan Cohen; John D Fraser; Shiranee Sriskandan
The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(5):2561-9.
2002: W P Hanage; Jonathan Cohen
Stimulation of cytokine release and adhesion molecule expression by products of Viridans streptococci.
The Journal of infectious diseases 2002;185(3):357-67.
2001: Meera Unnikrishnan; Jonathan Cohen; Shiranee Sriskandan
Complementation of a speA negative Streptococcus pyogenes with speA: effects on virulence and production of streptococcal pyrogenic exotoxin A.
Microbial pathogenesis 2001;31(3):109-14.
2001: Shiranee Sriskandan; Meera Unnikrishnan; T Krausz; Hamlata Dewchand; Susan Van Noorden; Jonathan Cohen; Daniel M Altmann
Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice.
The Journal of infectious diseases 2001;184(2):166-73.
2001: Jonathan Cohen; G Guyatt; gordon bernard; T Calandra; D Cook; Diana Elbourne; J Marshall; A Nunn; S Opal
New strategies for clinical trials in patients with sepsis and septic shock.
Critical care medicine 2001;29(4):880-6.
2001: Martin Llewelyn; Jonathan Cohen
New insights into the pathogenesis and therapy of sepsis and septic shock.
Current clinical topics in infectious diseases 2001;21():148-71.
2001: M Llewelyn; Jonathan Cohen
Superantigen antagonist peptides.
Critical care (London, England) 2001;5(2):53-5.
2000: Shiranee Sriskandan; Geoffrey Kemball-Cook; D Moyes; J Canvin; E Tuddenham; Jonathan Cohen
Contact activation in shock caused by invasive group A Streptococcus pyogenes.
Critical care medicine 2000;28(11):3684-91.
2000: Shiranee Sriskandan; Meera Unnikrishnan; Thomas Krausz; Jonathan Cohen
Mitogenic factor (MF) is the major DNase of serotype M89 Streptococcus pyogenes.
Microbiology (Reading, England) 2000;146 ( Pt 11)():2785-92.
2000: Shiranee Sriskandan; Jonathan Cohen
Kallikrein-kinin system activation in streptococcal toxic shock syndrome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(6):961-2.
1999: Meera Unnikrishnan; Jonathan Cohen; Shiranee Sriskandan
Growth-phase-dependent expression of virulence factors in an M1T1 clinical isolate of Streptococcus pyogenes.
Infection and immunity 1999;67(10):5495-9.
1999: Shiranee Sriskandan; Meera Unnikrishnan; T Krausz; Jonathan Cohen
Molecular analysis of the role of streptococcal pyrogenic Exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes.
Molecular microbiology 1999;33(4):778-90.
1999: Jonathan Cohen; E Abraham
Microbiologic findings and correlations with serum tumor necrosis factor-alpha in patients with severe sepsis and septic shock.
The Journal of infectious diseases 1999;180(1):116-21.
1999: Shiranee Sriskandan; Jonathan Cohen
Gram-positive sepsis. Mechanisms and differences from gram-negative sepsis.
Infectious disease clinics of North America 1999;13(2):397-412.